DENTSPLY SIRONA Inc. XRAY Cash Flow

Dentsply sirona inc. (XRAY)

CashFlow / Yearly

Dec'19	Dec'18	Dec'17	Dec'16	Dec'15	Dec'14	Dec'13	Dec'12	Dec'11	Dec'10	Dec'09	Dec'08	Dec'07
Cash flows from operating activities:
Net (loss) income
263,100	-1,010,900	-1,550,300	431,400	251,100	322,900	318,200	318,489	247,446	267,335	274,412	283,270	259,711
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:
Depreciation
133,200	132,900	127,300	116,600	79,100	81,200	81,600	79,456	64,039	56,868	54,087	47,887	42,628
Amortization of intangible assets
189,600	197,900	189,100	155,100	43,800	47,900	46,300	49,743	20,996	9,044	10,643	9,042	7,661
Amortization of deferred financing costs
2,700	2,700	2,600	4,500	11,300	4,600	5,000	7,045	8,023	428	445	-	-
Fixed asset impairment
33,400	0	0	-	-	-	-	-	-	-	-	-	-
Goodwill impairment
0	1,085,800	1,650,900	0	0	-	-	-	-	-	-	-	-
Indefinite-lived intangible asset impairment
5,300	179,200	346,700	0	0	-	-	-	-	-	-	-	-
Definite-lived intangible asset impairment
3,800	0	0	-	-	-	-	-	-	-	-	-	-
Deferred income taxes
-37,400	-62,000	-143,800	-110,100	27,400	17,500	-29,200	-65,527	-88,402	15,119	195	13,371	25,568
Stock based compensation expense
66,200	21,000	48,000	41,300	25,600	25,400	25,100	22,187	20,947	18,803	16,276	17,290	14,088
Restructuring and other costs - non-cash
16,100	22,500	64,700	9,700	43,300	5,800	14,000	20,229	2,460	379	369	8,303	190
Stock option income tax benefit
-	-	-	12,700	11,600	2,100	2,400	13,009	1,039	4,663	3,505	3,910	-
Net interest expense on derivatives with an other than insignificant financing element
-	-	-	-	-	-	-	-	-	1,635	0	-	-
Equity in earnings from unconsolidated affiliates
-	-	-	-	-1,600	-400	1,100	-3,270	2,351	-1,096	-	-	-
Other non-cash expense (income)
20,300	-3,400	-9,900	32,000	13,100	-10,000	-19,800	15,564	-20,938	-6,153	8,650	-19,654	-10,676
Loss (gain) on disposal of property, plant and equipment
-3,600	-4,600	-1,600	-2,800	-800	-400	-800	-808	-570	-113	1,997	-1,373	-1,904
Gain on divestiture of noncontrolling interest
8,700	0	0	-	-	-	-	-	-	-	-	-	-
Loss on sale on non-strategic businesses and product lines
-2,000	0	0	-	-	-	-	-	-	-	-	-	-
Excess tax benefits from share-based compensation
-	-	-	-	-	-	-	-	-	-	-	-	-11,414
Gain on sale of equity security
0	44,100	0	0	-	-	-	-	-	-	-	-	-
Accounts and notes receivable-trade, net
91,400	-23,500	63,400	75,100	900	-7,200	32,500	12,591	-1,469	-5,115	16,942	3,690	9,029
Inventories, net
-13,700	19,900	62,900	-65,400	-32,100	-21,000	25,400	36,792	-21,503	9,309	-27,710	32,824	-716
Prepaid expenses and other current assets, net
-13,000	27,100	75,000	32,400	9,500	16,100	-26,900	15,126	933	3,705	-6,996	1,220	644
Other noncurrent assets, net
8,500	12,700	3,700	-2,600	-3,300	-4,900	1,100	-853	1,560	1,154	192	-390	1,253
Accounts payable
26,100	7,100	44,200	7,200	8,800	10,000	-36,700	12,843	10,816	2,165	-4,947	5,430	-7,395
Accrued liabilities
45,300	300	28,300	-12,200	-4,700	-12,200	-4,200	-976	42,218	9,004	-1,708	5,748	-396
Income taxes
-15,800	12,100	-20,500	-7,700	-8,100	22,400	-500	22,105	26,139	2,786	8,104	4,594	59,421
Other noncurrent liabilities
-2,200	-16,500	8,200	9,000	17,100	9,200	13,200	-7,758	190	249	1,193	581	5
Net cash (used in) provided by operating activities
632,800	499,800	601,900	563,400	497,400	560,400	417,800	369,685	393,469	377,461	362,489	335,981	387,697
Cash flows from investing activities:
Proceeds from redemption of long-term corporate bonds
-	-	-	-	47,700	0	0	-	-	-	-	-	-
Liquidation of short term investments
1,000	0	0	-	-	1,100	0	-	6	0	222	314,025	73
Capital expenditures
122,900	182,500	144,300	125,000	72,000	99,600	100,300	92,072	71,186	44,236	56,481	76,440	64,163
Cash assumed in Sirona merger
-	-	-	522,300	0	0	-	-	-	-	-	-	-
Purchase of convertible debt issued by affiliate
-	-	-	-	-	-	-	-	-	49,654	0	-	-
Purchase of company owned life insurance policies
0	0	900	1,700	1,400	900	1,500	1,577	0	2,000	0	-	-
Cash received on derivative contracts
40,300	8,000	6,500	20,100	30,700	67,200	10,800	-	0	-	-	-	-
Cash paid for acquisitions of businesses and equity investments, net of cash acquired
3,200	130,500	145,900	341,800	54,000	8,600	66,200	4,861	1,787,516	35,556	2,986	117,300	101,492
Cash received on sale of non-strategic businesses or product lines
11,600	0	0	6,100	0	6,500	0	-	-	-	-	-	-
Purchase of short-term investments
0	3,700	2,500	6,800	0	2,300	0	-	-	-	-	166,208	138,471
Cash paid on derivatives contracts
0	2,400	0	17,100	6,300	96,500	104,900	14,221	25,575	34,978	0	-	-
Expenditures for identifiable intangible assets
0	5,500	6,700	1,100	0	6,200	1,100	3,329	3,068	1,606	14	2,477	1,665
Proceeds from the sale of equity security
0	54,100	0	0	-	-	-	-	-	-	-	-	-
Proceeds from sale of property, plant, and equipment, net
4,800	9,200	7,400	5,000	400	600	3,000	1,039	497	3,562	5,860	596	6,327
Net cash used in investing activities
-68,400	-253,300	-286,400	60,000	-54,900	-138,700	-260,200	-115,021	-1,886,842	-164,468	-53,399	-47,804	-299,391
Cash flows from financing activities:
Proceeds (repayments) on short-term borrowings, net
-68,500	60,400	10,200	-44,100	-2,200	-101,900	57,300	-228,912	270,209	-9,657	-7,465	2,111	-2,166
Excess tax benefits from stock based compensation
-	-	-	12,700	11,600	2,100	2,400	13,009	1,039	4,663	3,505	3,910	11,378
Cash paid for acquisition of noncontrolling interests of consolidated subsidiaries
-	-	-	400	80,500	0	9,000	-	16,088	0	0	-	-
Cash paid for treasury stock
260,000	250,200	401,400	813,900	112,700	163,200	118,000	38,837	79,500	223,993	78,718	112,634	125,422
Cash dividends paid
80,900	78,600	78,300	64,600	40,000	37,300	34,800	31,425	28,632	29,077	29,836	26,952	25,134
Proceeds from long-term borrowings, net of deferred financing costs
118,900	100	3,100	1,220,600	152,900	114,300	174,600	-	1,106,514	368,611	86,091	117,900	149,500
Repayments on long-term borrowings
251,200	9,400	16,700	877,500	267,500	199,200	251,400	-	251,932	242,137	58,403	226,147	50,543
Payments on terminated derivative instruments
-	-	-	-	-	-	-	-	-	0	0	-	-
Proceeds from exercised stock options
108,800	27,900	82,300	41,000	35,500	49,000	66,900	34,183	42,275	30,189	13,406	12,726	45,594
Cash paid for contingent consideration on prior acquisitions
33,200	0	0	-	-	-	-	2,519	3,023	0	0	-	-
Cash paid on derivative contracts
-	-	-	-	-	-	49,700	1,108	38,481	-	-	-	-
Payments for Derivative Instrument, Financing Activities
-	-	-	-	-	-	-	-	-	1,635	0	-	-
Net cash used in financing activities
-466,100	-249,800	-400,800	-526,200	-302,900	-336,200	-161,700	-255,609	1,002,381	-103,036	-71,420	-229,086	3,207
Effect of exchange rate changes on cash and cash equivalents
-3,000	-7,700	22,000	2,100	-6,600	-8,900	-1,000	3,949	28,082	-20,267	8,687	-24,484	12,807
Net decrease in cash and cash equivalents
95,300	-11,000	-63,300	99,300	133,000	76,600	-5,100	3,004	-462,910	89,690	246,357	34,607	104,320
Schedule of non-cash investing activities:
Merger financed by common stock
-	-	-	6,256,200	0	0	-	-	-	-	-	-	-
Supplemental disclosures of cash flow information:
Interest paid, net of amounts capitalized
30,200	35,100	37,000	36,700	54,900	47,800	50,500	60,166	34,048	21,856	23,231	34,222	21,926
Income taxes paid, net of refunds
112,100	104,700	122,700	112,300	71,400	48,700	49,800	109,544	58,646	64,787	76,207	66,696	38,091
Non-cash investing activities:
Property, plant and equipment in accounts payable at end of period
13,800	14,600	12,800	-	-	-	-	-	-	-	-	-	-
Exchange of inventory for naming rights
3,200	0	0	-	-	-	-	-	-	-	-	-	-